PREMIER Platinum HpSA PLUS
Helicobacter Pylori. 510(k) K182559, from Meridian Bioscience, Inc. (Cincinnati, OH). Product code LYR, class 1.
As of Nov 22, 2026, K182559 is an FDA 510(k) held by Meridian Bioscience, Inc., substantially equivalent on Nov 5, 2018 after 49 days, with no recalls tied to it in FDA's recall database.
- Review time: 49 days
- Recalls: 0
- Cited as a predicate by: 3 devices
The PREMIER Platinum HpSA PLUS enzyme immunoassay (EIA) is an in vitro qualitative procedure for the detection of Helicobacter pylori antigens in human stool. Test results are intended to aid in the diagnosis of H. pylori infection and to monitor response during and post-therapy in patients.
- Premier Platinum Hpsa Plus, Models 601396, 601480K053335 · Meridian Bioscience, Inc. · Mar 10, 2006
- Modification To: Premier Platinum HpsaK983255 · Meridian Diagnostics, Inc. · Dec 17, 1998
- Premier Platinum HpsaK980076 · Meridian Diagnostics, Inc. · May 12, 1998
- Hp Detect™ Stool Antigen ELISAK232892 · Biomerica, Inc. · Dec 15, 2023
- Premier HpSA Flex (619096)K230901 · Meridian Bioscience, Inc. · Jul 3, 2023
- Curian HpSA, Curian AnalyzerK192817 · Meridian Bioscience, Inc. · Mar 13, 2020
- Hp Detect™ Stool Antigen ELISAK232892 · Biomerica, Inc. · Dec 15, 2023
- Premier HpSA Flex (619096)K230901 · Meridian Bioscience, Inc. · Jul 3, 2023
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Sep 17, 2018
- Review panel
- Microbiology
- Regulation
- 21 CFR 866.3110
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files